School of Medicine
Showing 11,301-11,350 of 13,097 Results
-
Ryan Taylor, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Taylor is a fellowship-trained neurologist and assistant professor in the Department of Neurology and Neurological Sciences, Memory Disorders Division. He provides patient care at the Stanford Center for Memory Disorders.
His areas of expertise include diagnosing and treating illnesses that impair thinking, memory, behavior, and speech. Dr. Taylor’s clinical focus includes Alzheimer’s disease, Lewy body disease, frontotemporal dementia, primary progressive aphasia, posterior cortical atrophy, Creutzfeldt-Jakob disease, autoimmune encephalitis and other rapidly progressive dementias. He works with patients and families to provide diagnostic clarity and individualized treatment plans.
Dr. Taylor’s academic and research interests combine clinical and scientific understandings of dementia with a philosophical inquiry into the structure of conscious experience. His original clinical research includes diverse topics, such as advances in diagnosing Creutzfeldt-Jakob disease and the clinical characterization of adult-onset hereditary dementias. Dr. Taylor has published work instrumental in identifying the potential role of fentanyl in a syndrome of sudden onset amnesia that emerged during the opioid crisis.
He has presented research at the American Academy of Neurology and published in peer-reviewed journals, including the Canadian Journal of Neurological Sciences and Methods in Molecular Biology. He has also published a chapter on the diagnosis and treatment of frontotemporal dementia and was a reviewer for Neurocase.
Dr. Taylor is a fellow of the Royal College of Physicians of Canada. He has taught residents and medical students clinical skills, neuroanatomy, neuro-imaging, and other subjects. He also has delivered Grand Rounds presentations on dementia, epilepsy, and pediatric neurology. -
David Tehrani, MD, MS
Affiliate,
BioDr. Tehrani is a board-certified, fellowship-trained interventional cardiologist with Stanford Health Care Tri-Valley in the East Bay.
He is focused on building long-term relationships with his patients and their families, while sharing his evidence-based expertise in the noninvasive and minimally invasive management of cardiovascular disease. He takes pride in forming care plans based on mutual decision-making.
Dr. Tehrani’s research interests include cutting-edge technology and advancements in medical management of cardiovascular disease. His clinical research studies and funded clinical research trials have focused on cardiovascular biomarkers, coronary physiology, cardiac hemodynamics, cardio-oncology, and procedural closure devices. His research background has been instrumental in helping him provide individualized, evidence-based care plans for conditions ranging from advanced heart failure to complex coronary disease.
Dr. Tehrani has an extensive clinical research background, with over 40 peer-reviewed publications in top cardiology journals. He has done over 30 presentations at conferences, including the American Heart Association (AHA) and American College of Cardiology (ACC) national meetings.
Dr. Tehrani is a member the American College of Cardiology, the American College of Physicians, the American Heart Association, the Heart Failure Society of America, and the International Society of Heart and Lung Transplantation. -
Nicholas Telischak, MD, MS
Clinical Associate Professor, Radiology
Clinical Associate Professor (By courtesy), NeurosurgeryBioA native of the Bay Area, Dr. Nick Telischak is a dual fellowship-trained neurointerventional surgeon and neuroradiologist at Stanford Health Care. With board certifications in radiology and neuroradiology, he serves as a clinical associate professor in the Department of Radiology, and, by courtesy of the Department of Neurosurgery, at Stanford School of Medicine.
Dr. Telischak specializes in diagnosing and treating artery disorders in the brain and spine, including brain aneurysms, arteriovenous malformations (AVM), and dural arteriovenous fistula (dAVF), and stroke. Dr. Telischak also specializes in venous disorders in the brain including idiopathic intracranial hypertension (IIH). He also has a special interest in pulsatile tinnitus, a whooshing sound in the ears that occurs in rhythm with the heartbeat. Dr. Telischak also treats painful spinal (vertebral) fractures, spinal metastases (tumors resulting from cancer elsewhere in the body), and congenital vascular malformations (blood vessel abnormalities that are present at birth). He treats these conditions using minimally invasive, image-guided procedures and state-of-the-art technology.
Prior to joining Stanford Health Care, Dr. Telischak helped develop the Stroke Program at California Pacific Medical Center and Mills-Peninsula Medical Center, giving him a broad perspective on medical care systems within the Bay Area.
Dr. Telischak’s research focuses on:
• Identifying biomarkers to diagnose large vessel occlusion stroke (stroke in one of the large arteries in the brain)
• Noninvasive MRI techniques for diagnosing idiopathic intracranial hypertension (high pressure within the skull)
He is also the principal investigator for a study examining the efficacy of vertebroplasty and kyphoplasty for the treatment of painful vertebral compression fractures.
In addition, Dr. Telischak holds a master’s degree in bioengineering. He has worked with several companies pioneering new devices to treat brain aneurysms, vascular malformations, and strokes caused by blood clots, as well as new treatments for venous disorders in the brain caused by idiopathic intracranial hypertension.
Dr. Telischak has published more than 20 peer-reviewed articles and has been invited to present locally, nationally, and internationally at meetings for the Society of NeuroInterventional Surgery, American Society of Neuroradiology, and Jornada de Stroke in Asuncion, Paraguay, where he has served as visiting faculty. -
Melinda L. Telli, M.D.
Professor of Medicine (Oncology)
Current Research and Scholarly InterestsMy research focuses on the development of novel therapies for the treatment of triple-negative and hereditary cancer. Other areas of interest include prevention of cardiac damage associated with breast cancer treatment and cardiotoxicity of anti-cancer agents.
-
Joyce Teng, MD, PhD
Professor of Dermatology and, by courtesy, of Pediatrics
BioJoyce Teng, MD, PhD is a professor in dermatology at Stanford University. She is affiliated with multiple hospitals in the area, including Lucile Salter Packard Children's Hospital (LPCH) at Stanford and Stanford Hospital and Clinics (SHC). She received her medical degree from Vanderbilt University School of Medicine and has been in practice for more than 12 years. She is one of the 6 pediatric dermatologists practicing at LPCH and one of 72 at SHC who specialize in Dermatology. She sees patients with rare genetic disorders, birthmarks, vascular anomalies and a variety of inflammatory skin diseases. She is also an experienced pediatric dermatological surgeon. Her research interests are drug discovery and novel therapy for skin disorders.
-
Nelson Teng
Professor of Obstetrics and Gynecology (Oncology), Emeritus
Current Research and Scholarly InterestsGynecologic Malignancies
Immunotherapy
Biologic Response Modifiers
New Drug Development
Antigenic specificities of human antibodies encoded by the VH4-34 gene -
Valerie Teng
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Valerie Teng is a board certified family physician with special interests in preventative medicine and women's health. Her experiences in caring for patients with chronic conditions, such as diabetes and hypertension, have fueled her desire to partner with patients to enter healthier lifestyles. She is also passionate about providing comprehensive care to patients of all ages, including newborns and teens.
During her residency training, Dr. Teng explored many opportunities in medical education through the O’Connor-Stanford Leaders in Education Residency (OSLER) program. She is delighted to continue in medical education as a part of the faculty at Stanford Family Medicine. -
Azusa Terasaki
Postdoctoral Scholar, Pathology
BioAzusa Terasaki, MD, PhD, is a Postdoctoral scholar in the Department of Pathology at Stanford University School of Medicine. Her research focuses on tumor immunology and cancer metabolism, with a particular interest in mitochondrial transfer between cancer and immune cells and its role in immune suppression and metastasis.
Dr. Terasaki received her medical degree and PhD in Japan, where she completed her surgical training and is a board-certified surgeon with additional certifications as a breast specialist and in cancer therapy. During her clinical career, she developed a strong interest in translational research that bridges fundamental discoveries and patient care.
Her current work investigates how cancer cells reprogram immune cells through organelle transfer, integrating imaging, flow cytometry, and multi-omic approaches to uncover novel mechanisms of tumor–immune interaction. Her goal is to identify new therapeutic targets and biomarkers to improve cancer treatment outcomes. -
Stefano Testa
Instructor, Medicine - Oncology
BioDr. Testa is a medical oncologist and physician-scientist specializing in cellular therapy and the care of patients with soft tissue and bone sarcomas. He earned his medical degree from the University of Naples Federico II in Naples, Italy. He subsequently moved to the United States and conducted research in the laboratory of Dr. Ronald Levy at Stanford University, where he studied intratumoral vaccination strategies and mRNA delivery platforms designed to target B cells and T cells in vivo. He completed his internal medicine residency at Stanford University, followed by a fellowship in hematology and oncology at Beth Israel Deaconess Medical Center. Dr. Testa’s research focuses on identifying targets for adoptive T-cell therapies in solid tumors, particularly soft tissue and bone sarcomas, and on novel synthetic biology approaches to enhance the effectiveness of T-cell therapies against solid tumors.
-
Jeffrey Teuteberg
Professor of Medicine (Cardiovascular Medicine)
BioHe is currently a Professor of Medicine at Stanford, but is no longer seeing patients as he is on leave and working with industry.
His research interests are in clinical outcomes in patients after transplant and mechanical support as well as novel approaches to immunosuppression. He has participated in many single-center and multi-institutional research studies and has published widely in the fields of transplant and mechanical support. He served as President of the International Society of Heart and Lung Transplantation in 2018. -
Winifred Teuteberg
Clinical Professor, Medicine - Primary Care and Population Health
BioDr. Teuteberg completed residency training in Internal Medicine at the University of Chicago and a Palliative Medicine Fellowship at Massachusetts General Hospital. She joined the faculty at Stanford in 2017 and currently sees patients as a part of the inpatient palliative care consult team at Stanford Healthcare.
She has been the clinical director or Stanford Medicine's implementation of the Ariadne Labs' Serious Illness Care Program since its inception in 2018. Her interests include communication skills training, leveraging predictive algorithms to identify patients who would most benefit from serious illness conversations, how to empower non-physician clinical team members to participate in this work, and best practice for EHR builds related to advance care planning. -
Haluk Tezcan, MD
Adjunct Clinical Associate Professor, Medicine - Oncology
BioClinical focus:
Breast Oncology
Molecular Diagnostics
Dr. Tezcan is a medical oncologist and hematologist with over three decades of diverse experience in cancer management and research.
He is leading the clinical development of Droplet Biosciences' novel liquid biopsy technology, a first-in-class lymphatic fluid molecular residual disease assessment, overseeing the scientific and clinical development of the technology. With over three decades of direct patient care and clinical trial experience as a principal investigator and director, both in academia and private practice, he has a firsthand understanding of the unmet clinical needs of physicians and patients, as well as broad experience in clinical trial design and implementation.
He is also co-principal at Athea Oncology, guiding practices and hospitals in developing clinical trial programs and high-value real-world data collection and diagnostic companies in clinical development. He is also a reviewer of JCO Precision Medicine.
Before joining Athea Oncology and Droplet Biosciences, he was the co-founder of LexentBio, which was successfully acquired by Roche/FMI. He also served as Director of Translational Medicine at Genomic Health and as Vice President, leading oncology development at Counsyl, where he integrated science with clinical product development. He established the CA.RE.foundation, a cancer research foundation dedicated to enabling the execution of clinical trials across community oncology sites throughout the Northwest US. He has independently built multiple software tools to help oncologists navigate the practical realities of their daily work. -
Sonoo Thadaney Israni
Executive Director, Presence + Program in Bedside Medicine, Med/Program/Bedside Med
Current Role at StanfordExecutive Director, Presence (med.stanford.edu/presence.html) & Program in Bedside Medicine/Stanford 25 (stanfordmedicine25.stanford.edu)
Instructor Stanford University School of Medicine - Authentic Courage for Constructive Change: Skills and Practice for Leadership
LinkedIn Profile: www.linkedin.com/in/sonoo/
